Skip to content
10-Q

Quarterly Report

Humacyte, Inc. HUMA HUMAW

0001193125-26-221755

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 222.02M sh
Shares Diluted Q1 2026 · Mar 31, 2026 197.85M sh
Shares Diluted Q1 2026 · Mar 31, 2025 131.76M sh
Capex Q1 2026 · Mar 31, 2026 $175K
Capex Q1 2026 · Mar 31, 2025 $228K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$25.1M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$28.6M
Long Term Debt Q1 2026 · Mar 31, 2026 $35.87M
Long Term Debt Q1 2026 · Dec 31, 2025 $35.44M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $48.54M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $50.5M
Stockholders Equity Q1 2026 · Mar 31, 2026 $11.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 $3.11M
Stockholders Equity Q1 2026 · Mar 31, 2025 $36.04M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$52.67M
Current Liabilities Q1 2026 · Mar 31, 2026 $16.19M
Current Liabilities Q1 2026 · Dec 31, 2025 $18.37M
Total Liabilities Q1 2026 · Mar 31, 2026 $98.93M
Total Liabilities Q1 2026 · Dec 31, 2025 $113.26M
Current Assets Q1 2026 · Mar 31, 2026 $63.6M
Current Assets Q1 2026 · Dec 31, 2025 $67.8M
Total Assets Q1 2026 · Mar 31, 2026 $110.56M
Total Assets Q1 2026 · Dec 31, 2025 $116.37M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.09
Eps Diluted Q1 2026 · Mar 31, 2025 $0.28
Eps Basic Q1 2026 · Mar 31, 2026 −$0.09
Eps Basic Q1 2026 · Mar 31, 2025 $0.28
Rd Expense Q1 2026 · Mar 31, 2026 $19.46M
Rd Expense Q1 2026 · Mar 31, 2025 $15.42M
Net Income Q1 2026 · Mar 31, 2026 −$17.62M
Net Income Q1 2026 · Mar 31, 2025 $39.14M
Operating Income Q1 2026 · Mar 31, 2026 −$28.94M
Operating Income Q1 2026 · Mar 31, 2025 −$23.18M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $2.04M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $147K
Revenue Q1 2026 · Mar 31, 2026 $495K
Revenue Q1 2026 · Mar 31, 2025 $517K